ProfileGDS4718 / 210188_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 45% 52% 34% 46% 46% 61% 56% 54% 39% 50% 49% 54% 57% 60% 52% 53% 50% 56% 51% 32% 54% 51% 52% 54% 48% 57% 47% 44% 39% 49% 52% 50% 41% 58% 60% 51% 43% 48% 49% 43% 49% 48% 43% 65% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.2249745
GSM549102patient 115, normal, homogenized [OPG study]5.6223152
GSM549104patient 119, normal, homogenized [OPG study]4.7075934
GSM549108patient 138, normal, homogenized [OPG study]5.349746
GSM549119patient 077, normal, homogenized [OPG study]5.3097246
GSM549133patient 032, cancer, homogenized [OPG study]6.1558661
GSM549139patient 042, cancer, homogenized [OPG study]5.8774356
GSM549099patient 107, normal, homogenized [OPG study]5.7291654
GSM549109patient 139, normal, homogenized [OPG study]4.9862939
GSM549110patient 046, normal, homogenized [OPG study]5.5380150
GSM549114patient 063, normal, homogenized [OPG study]5.4330649
GSM549122patient 082, normal, homogenized [OPG study]5.7335354
GSM549134patient 033, cancer, homogenized [OPG study]5.8770857
GSM549136patient 036, cancer, homogenized [OPG study]6.0731760
GSM549140patient 044, cancer, homogenized [OPG study]5.5750952
GSM549111patient 047, normal, homogenized [OPG study]5.6876853
GSM549113patient 057, normal, homogenized [OPG study]5.4581950
GSM549132patient 031, cancer, homogenized [OPG study]5.8409956
GSM549137patient 038, cancer, homogenized [OPG study]5.5467851
GSM549142patient 047, cancer, homogenized [OPG study]4.7601232
GSM549100patient 110, normal, homogenized [OPG study]5.7368854
GSM549107patient 135, normal, homogenized [OPG study]5.5391851
GSM549115patient 068, normal, homogenized [OPG study]5.5896852
GSM549116patient 072, normal, homogenized [OPG study]5.7291354
GSM549120patient 078, normal, homogenized [OPG study]5.3737748
GSM549131patient 030, cancer, homogenized [OPG study]5.9233257
GSM549118patient 074, normal, homogenized [OPG study]5.3366847
GSM549129patient 027, cancer, homogenized [OPG study]5.2164844
GSM549123patient 088, normal, homogenized [OPG study]4.9383239
GSM549124patient 006, cancer, homogenized [OPG study]5.4829149
GSM549126patient 015, cancer, homogenized [OPG study]5.6040752
GSM549128patient 025, cancer, homogenized [OPG study]5.5133750
GSM549103patient 117, normal, homogenized [OPG study]5.1113941
GSM549117patient 073, normal, homogenized [OPG study]5.9645458
GSM549138patient 041, cancer, homogenized [OPG study]6.1213860
GSM549141patient 045, cancer, homogenized [OPG study]5.5445951
GSM549130patient 028, cancer, homogenized [OPG study]5.1660443
GSM549101patient 111, normal, homogenized [OPG study]5.461648
GSM549105patient 128, normal, homogenized [OPG study]5.4709449
GSM549106patient 134, normal, homogenized [OPG study]5.080643
GSM549112patient 048, normal, homogenized [OPG study]5.4398549
GSM549125patient 011, cancer, homogenized [OPG study]5.3991948
GSM549127patient 024, cancer, homogenized [OPG study]5.1636443
GSM549135patient 035, cancer, homogenized [OPG study]6.4655365